A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

Masanori Miwa, Masako Ura, M Nishida et al. · European Journal of Cancer · 1998 · 1.2K citations

Medicine, Oncology, Pharmacology +12

Patient preferences for oral versus intravenous palliative chemotherapy.

Geoffrey Liu, E. Franssen, Margaret I. Fitch et al. · Journal of Clinical Oncology · 1997 · 920 citations

Medicine, Oncology, Chemotherapy +14

Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer

Joanne L. Blum, Stephen E. Jones, Aman U. Buzdar et al. · Journal of Clinical Oncology · 1999 · 791 citations

Medicine, Oncology, Pharmacology +16

Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients

Joanne L. Blum, V�ronique Dieras, Patricia Mucci Lo Russo et al. · Cancer · 2001 · 402 citations · Full text

Medicine, Oncology, Pharmacology +17

Capecitabine, an Oral Fluoropyrimidine Carbamate With Substantial Activity in Advanced Colorectal Cancer: Results of a Randomized Phase II Study

Eric Van Cutsem, Michael Findlay, B Osterwalder et al. · Journal of Clinical Oncology · 2000 · 322 citations

Medicine, Oncology, Pharmacology +16